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ABSTRACT SOX1 is a member of the SOXB1 subgroup
of transcription factors involved in early embryogenesis,
CNS development and maintenance of neural stem cells.
The structure and regulation of the human SOX1 locus has
been less studied than that of SOX2, another member of the
SOXB1 subgroup for which an overlapping transcript has
been reported. Here we report that the SOX1 locus harbours
a SOX1 overlapping transcript (SOX1-OT), and describe
expression, splicing variants and detection of SOX1-OT in
different stem and cancer cells. RT-PCR and RACE
experiments were performed to detect and characterise the
structure of SOX1-OT in neuroprogenitor cultures and
across different cancer cell lines. SOX1-OT was found to
present a complex structure including several unannotated
exons, different transcript variants and at least two poten-
tial transcription start sites. SOX1-OT was found to be
highly expressed in differentiated neural stem cells across
different time points of differentiation, and its expression
correlated with SOX1 gene expression. Concomitant
expression of SOX1 and SOX1-OT was further observed in
several cancer cell models. While the function of this
transcript is unknown, the regulatory role reported for other
lncRNAs strongly suggests a possible role for SOX1-OT in
regulating SOX1 expression, as previously observed for
SOX2. The elucidation of the genetic and regulatory con-
text governing SOX1 expression will contribute to
clarifying its role in stem cell differentiation and
tumorigenesis.
Keywords Stem cell  LncRNA  SOX1-OT 
Expression pattern  Cancer model  SOX1
Introduction
SOX1 and SOX2 are two closely related transcription
factors belonging to the SOXB1 subgroup of the high
mobility group box (HGM-box) family greatly involved in
the regulation of pluripotent stem cells and neural stem
cells [1]. In human, the SOX2 gene maps to Chr3q26.3,
within an intron of a long non-coding RNA (LncRNA)
called SOX2 overlapping transcript (SOX2-OT; Fig. 1a)
[2]. LncRNAs, defined as non-coding RNAs (ncRNAs) that
are more than 200 nucleotides long, have been suggested to
play a role in several biological processes including nuclear
organisation, epigenetic regulations and post-translational
modifications [3, 4]. This structure is conserved between
mouse and human, and in both species the SOX2 overlap-
ping transcripts are reported to have multiple transcription
start sites (TSS) and to be transcribed into several alter-
native transcript variants [5]. Recently, concomitant gene
expression of SOX2 and SOX2-OT has been reported in
breast, lung and oesophageal carcinoma [6–8]. Current
studies suggest a positive role for SOX2-OT in regulating
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SOX2, and concordant gene expression has been reported
in cellular differentiation, pluripotency and carcinogenesis
[5–7, 9]. SOX2-OT is differentially spliced into multiple
transcript variants in stem and cancer cells, and has been
proposed to play a role in regulating expression of SOX2
[9, 10].
SOX1, another SOXB1 member closely related to SOX2,
is involved in early embryogenesis, CNS development and
maintenance of neural stem cells [11]. SOX1 and SOX2
originated from a common ancestor by gene duplication
during the course of evolution and exhibit similar
sequences, expression patterns and overexpression pheno-
types [12]. The structure and regulation of the human SOX1
locus has been studied far less than that of SOX2, and there
has been no report of any overlapping transcript for this
gene. Here we address this question and describe the
complex structure of the SOX1 locus which was found to
harbour an overlapping transcript, and describe expression,
splicing variants and detection in different stem cell and
cancer cell models.
Fig. 1 Structural similarity between SOX2 and SOX1 loci. a Snap-
shot images of the human SOX2 locus on human chromosome 3 taken
from the UCSC genome browser showing the SOX2 gene itself (top)
and the zoomed out region (below) to emphasise the length and
alternative isoforms of the SOX2-OT non-coding gene within which
SOX2 lies. b Snapshots of the human SOX1 locus on human
chromosome 13 taken from the UCSC genome browser showing that
similarly to SOX2, the SOX1 gene is annotated within a larger non-
coding gene (LINC00403, top panel), and that there are two isoforms
for this gene currently annotated (bottom panel, red arrows). The
regions highlighted in blue in a and b are the SOX2 and SOX1 genes,
respectively
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Materials and methods
Reagents were purchased from ThermoFisher (UK) unless
otherwise stated.
Cell sample preparation
Cells lines used in this study are described in Table 1.
Ntera2, hMSCs, HeLa, SH-SY5Y and HOS cell lines were
grown in Dulbeco’s Modified Eagle Medium (DMEM)
supplemented with 10% foetal calf serum (FCS), 1% L-
glutamine, 1% non-essential amino acids and 0.5% Peni-
cillin/streptomycin, and incubated in a humidified
incubator in an atmosphere of 5% CO2 at 37 C. Cell
culture conditions for MDA-MB-361, MDA-MB-231 and
T47D are defined in [13], CaCo2, HCT116 and MCF7 in
[14], Hs578T in [15]. For RNA extraction, cell monolayers
were washed with PBS, detached with 0.05% trypsin/
EDTA and pelleted for 5 min. Cell pellets were stored in
TRI reagent (Sigma-Aldrich) at -80 C.
For neural differentiation samples, human immortalised
neuroprogenitor cells (ReNcell Merck Millipore, referred
to as ‘ReN’) were cultured according to manufacturer’s
instructions. Cells were seeded on laminin (Trevigen) in
ReNcell NSC Maintenance Medium (Merck Millipore)
supplemented with 20 ng/mL FGF2 and 20 ng/mL EGF.
After 24 h incubation (day 0, D0), cells were treated with
medium deprived of FGF and EGF to induce differentia-
tion for up to day 6 (D6). At stated time points, RNA was
harvested and processed as described below.
Immunostaining
Cells were fixed with 4% paraformaldehyde (PFA), washed
with PBS and incubated in PBS ? 0.1% Triton X-100 for
10 min before blocking with a 10% serum dilution. After
PBS wash, samples were incubated with a dilution of pri-
mary antibody against NESTIN (1:100, cat. # IC1259F,
R&D Systems, Abingdon, UK) or MAP2 (1:100, MT-01,
ExBio, Vestec, Czech Republic) overnight at 4 C, before
extensive washing, incubation in a FITC-labelled sec-
ondary antibody solution (1:500, FI-2000, Vector
laboratories, Peterborough, UK) for 1 h at room tempera-
ture, further washing and finally mounting with DAPI-
containing Vectashield (H-1200, Vector laboratories).
RNA extraction
Total RNA was extracted using 0.5 mL of TRI-Reagent
(Sigma-Aldrich) per 1–5 9 106 cells according to the
manufacturer’s protocol, followed by RNA purification
from the aqueous phase using the RNA Clean & Concen-
trator-25 kit (Zymo Research). RNA concentration was
determined spectrophotometrically and the samples were
stored at -80 C.
cDNA synthesis and RT-PCR
RNA samples were subjected to DNAse-I treatment using
the DNase-I, Amplification grade kit according to the
manufacturer’s protocol, using 1 U/lL of DNase-I for each
1 lg of RNA at 25 C for 20 min. After DNase-I treat-
ment, 2 lg RNA was used to synthesise cDNA by reverse
transcription using 200 units/lL of SuperScript III Reverse
Transcriptase in 30 lL of total reaction volume, including
100 pmol/lL of random 15mer primers (MWG Biotech),
0.5 mM dNTP and 0.1 mM DTT. Tubes containing the
reaction mix without reverse transcriptase (‘-RT’) were
used as negative control. cDNA samples were cleaned up
Table 1 Cell lines used in the experimental study
No. Cell line Tissue Cell type References
1 Ntera2 Testis Pluripotent embryonal carcinoma [16]
2 hMSCs Bone marrow Mesenchymal progenitors [17]
3 ReN cells Brain Neural progenitors [18]
4 HeLa Cervix Adenocarcinoma [19]
5 SH-SY5Y Bone marrow Neuroblastoma [20]
6 HOS Bone Osteosarcoma [21]
7 CaCo2 Colon Colorectal Adenocarcinoma [22]
8 HCT116 Colon Colorectal Carcinoma [23]
9 MCF7 Mammary gland Adenocarcinoma [24]
10 MDA-MB-361 Mammary gland Adenocarcinoma [25]
11 MDA-MB-231 Mammary gland Adenocarcinoma [25]
12 Hs578T Mammary gland Carcinoma [26]
13 T47D Mammary gland Ductal carcinoma [27]
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using MinElute PCR purification kit (Qiagen) and stored at
-20 C.
PCR amplification of cDNA was performed in a volume
of 20 lL using Platinum Taq DNA polymerase. Thermal
cycler conditions used after heating at 95 C for 10 min
involved 40 cycles of denaturation at 95 C for 30 s,
annealing at 55 C for 60 s and extension at 72 C for 60 s,
followed by a final 7-min extension step at 72 C. PCR
reactions set using either water instead of cDNA (‘H2O’) or
-RT samples as template were used as controls to rule out
any contamination issues.
PCR products were analysed by electrophoresis on 2%
agarose gels. Primers used for the SOX1-OT amplification
are shown in Supplementary Table 1. All fragments
detected by RT-PCR were sequenced (Source BioScience,
Nottingham, UK) to confirm specificity and map their
position.
Quantitative polymerase chain reaction (qRT-PCR)
For gene quantification by real-time PCR, Taqman qPCR
assays were performed in 20 lL reaction volumes con-
taining 10 lL Taqman Gene Expression Master Mix
(Applied Biosystems), 1 lL Taqman gene expression assay
and 5 lL distilled water. Taqman assays used were Ref.
Hs01057642_s1 for SOX1 and three reference genes
YWHAZ (Ref: Hs03044281_g), GAPDH (Ref:
Hs02758991_g1) and HPRT1 (Ref: Hs02800695_m1).
qPCR was performed on an Applied Biosystem Fast 7500,
with 50 cycles including a hold stage at 94 C for 5 min
followed by denaturation step at 94 C for 30 s and then
annealing at specific primer temperatures for 45 s, fol-
lowed by extension at 72 C for 1 min.
Statistical analysis
For relative gene quantification of SOX1 mRNA at different
time points of neural differentiation, qPCR Ct values were
normalised to the geometric mean of those of three reference
genes (GAPDH, HPRT1 and YWHAZ) according to MIQE
guidelines [28]. Fold changes in gene expression were nor-
malised to ReN cells at day 0 (2-DDCt). One-way ANOVA
with post hoc Tukey test was carried out for multiple
comparison. Three technical replicates were used (n = 3),
p value obtained\0.0001, 95% confidence interval, error
bars represent ±RQ, Statistical software Graphpad prism 6
was used: ***p\ 0.001; ****p\ 0.0001.
Bioinformatics analysis
The UCSC Blat [29] was used for the alignment of RT-
PCR/50RACE product sequences and the Blat results were
then visualised using UCSC genome browser (https://
genome.ucsc.edu) [30], Human Feb. 2009 (GRCh37/hg19)
assembly [31]. FANTOM5 project tracks (http://fantom.
gsc.riken.jp/5/) provided the TSS activities in individual
biological states and the regions identified by CAGE (Cap
Analysis Gene Expression) [32]. The ECR browser (http://
ecrbrowser.dcode.org/) [33] was used to visualise and
analyse Evolutionary Conserved Regions (ECRs) of SOX1-
OT sequence across different species.
For RNA sequencing analysis, publicly available data-
sets were downloaded from the European nucleotide
archive (ENA, http://www.ebi.ac.uk/ena). Paired-end
RNA-seq [non-stranded, Poly(A)-enriched] was obtained
in biological triplicates for a neural differentiation from H1
human neural progenitors on day 0, 1, 2, 4, 5, 11 and 18
(Array Express: E-GEOD-56785) [34]. After trimming the
data using Trimmomatic [35] (first 10 bp, quality trim-
ming), the reads were mapped to the human reference
(Ensembl GRCh38) using HISAT2 [36]. For each sample,
the transcriptome was assembled using StringTie [37]
imposing a 2 read minimum for each splice site. The
obtained transcriptomes were merged for the biological
replicates and visualised using the IGV browser [38].
50RACE
50RACE experiments were carried out using the 50RACE
System for Rapid Amplification of cDNA Ends, version
2.0. All the steps were carried out according to manufac-
turer’s protocol using 2.5 lg DNAase I digested RNA
from ReN cells differentiated at day 6, and SOX1-OT-
specific primer pairs were GSP1, GSP2 and GSP3 with an
annealing temperature of 60 C (sequences available upon
request). 50RACE products were gel-purified with a gel
extraction kit (Qiagen) and cloned using the TA cloning kit
(Promega) according to the manufacturer’s instructions.
Positive clones were analysed by Sanger sequencing
(Source Biosciences); sequences obtained were aligned to
the UCSC Genome Browser on Human Feb 2009
(GRCh37/hg19) Assembly.
Results
Comparative analysis of human and mouse Sox1-OT
structure
Human SOX2 and SOX1 loci were analysed and revealed a
high structural similarity (Fig. 1). Similar to SOX2, SOX1
is also embedded within an intron of a LncRNA gene
(referred hereafter as SOX1-OT), LINC00403, annotated in
the NCBI RNA reference sequence collection (RefSeq)
[30]. Two transcript variants were found annotated in
RefSeq data, LINC00403 v1 and LINC00403 v2, but only
A. Ahmad et al.
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transcript v1 showed overlap with the SOX1 gene (Fig. 1b).
LINC00403 is annotated as a 135.706 genomic region
found on human chromosome 13: 112626624-112762329,
giving rise to a 704 bp long RNA [30]. The LINC00403
structure has a validated status in RefSeq, and the reference
sequences were derived from three different tissues,
amygdala (GenBank: DA195709.1), foetal eye (GenBank:
BQ184460.1.1) and Lung-carcinoid (GenBank:
AI693652.1).
Given the evolutionary conservation of the human
SOX2-OT [5], multiple sequence alignment of the anno-
tated human SOX1-OT genomic locus against different
vertebrate species was carried out to evaluate the level of
evolutionary conservation of the transcript (Fig. 2a) [33].
The comparative sequence alignment revealed some evo-
lutionary conserved regions (ECR) across different
vertebrate species, including an ECR towards the 30end of
SOX1-OT corresponding to an exon of the annotated mouse
Sox1 overlapping transcript GM5607 that was not found in
the human annotation (Fig. 2b). Human–mouse alignment
of this region demonstrated high level of sequence con-
servation ([99%; Supplementary Fig. 1A), which allowed
the design of primers compatible with both human and
mouse templates for experimental validation. RT-PCR
performed using these primers confirmed that this region
was expressed in mouse embryonic and neural stem cells
(mESC and mNSC, respectively), and also revealed its
expression in human cells with neural differentiation
potential (NTera, ReN, SH-SY5Y) (Supplementary
Fig. 1B, C). The detection of this yet unannotated exon,
together with the presence of the several ECR highlighted
by the cross-species comparison, suggested a possible
conserved role for this transcript.
Structural architecture of SOX1-OT in ReN cells
Based on the initial strong signal for SOX1-OT in ReN
cells, these cells were further used to characterise the
structure of SOX1-OT using two parallel and complemen-
tary approaches: RT-PCR using primers in annotated exons
of SOX1-OT, and 50RACE to identify the transcription start
site (TSS) of SOX1-OT (Fig. 3). RT-PCR revealed the
presence of three new exons (in green in variants 3–6,
Fig. 3b). 50RACE primed in the last annotated exon
uncovered two additional exons at the 50 end of the tran-
script (in green in variants 8–11, Fig. 3b), the furthest 50 of
which was further validated by RT-PCR (variant 7,
Fig. 3b).
The 50RACE analysis revealed two main TSS for SOX1-
OT located in close genomic proximity to the SOX1 gene
(Fig. 3c, bent arrows). To confirm the regulatory tran-
scriptional potential of these two TSS, an online
bioinformatics analysis was performed by aligning the
SOX1-OT sequence to the FANTOM5 project tracks
through the UCSC genome browser (Fig. 3c) [39]. The
FANTOM5 project provides genome-wide mammalian
gene expression data by mapping TSS, promoter regions
and enhancers in human and mouse primary cells, cell lines
and tissues [32]. The alignment highlighted two potential
transcriptional start sites with high peaks of Cap analysis
for gene expression (CAGE) reads that matched with the
TSS experimentally identified by 50RACE, providing fur-
ther support for the identity of the SOX1-OT TSS found in
ReN cells (Fig. 3c, red tracks).
SOX1-OT and SOX1 are co-expressed during neural
differentiation
To determine whether the different SOX1-OT variants were
expressed at different levels during neuronal differentia-
tion, ReN neuroprogenitor cells were differentiated over a
6-day time course, and tested as undifferentiated (D0) or
after 2, 4 and 6 days of neural differentiation. ReN cell
differentiation was confirmed by immunofluorescence at
D0 and D6 showing loss of the undifferentiated marker
Nestin and increase in MAP2 expression (a neuronal
marker) (Fig. 4a). Relative quantification of SOX1
expression in ReN cells over the 6-day differentiation
showed that SOX1 mRNA significantly increased at D2, D4
and D6 of differentiation compared to D0 (Fig. 4b).
SOX1-OT expression was analysed in these cells using
different primer pairs to test selected individual exons and
different transcript variants (Fig. 5a). Expression of exons
2, 7 and 10 was detected at all time points of differenti-
ation, with a significant increase in expression between D0
and D2 for all exons tested (Fig. 5b, left panel). Similarly,
transcript variants 3, 4, 5, 9 and 11 were expressed at very
low levels (variants 9 and 11) or not detected (variants 3, 4
and 5) in undifferentiated ReN cells (D0), but became
detectable from D2. Of particular note, there seemed to be
a switch in expression between variants 5 and 4, whereby
variant 5 was expressed at D2 but not at D4 and D6, when
variant 4 became more prominent (Fig. 5b). These results
indicate that during neural differentiation of ReN cells,
SOX1-OT expression pattern is similar to that of SOX1,
with a significant increase in expression observed at day 2
and 4 for both genes. Transcriptome analysis of publicly
available data for human embryonic stem cells (hESC
H1)-derived neural progenitors over a 18-day neural dif-
ferentiation time course supported the findings in ReN
cells [34]. The two TSS identified in ReN cells were also
found in differentiating hESC-derived neuroprogenitors, as
well as many of the variants identified experimentally
(Fig. 5c). Interestingly, this analysis revealed the existence
of additional variants in differentiating hESC-derived
neuroprogenitors, and also suggested that the gene
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Fig. 2 Cross-species comparative analysis of SOX1 overlapping
transcript loci. a Evolutionary conserved regions revealed in the
cross-species alignment of human assembly hg19 region
chr13:112626600–112765500 generated by the ECR browser (http://
ecrbrowser.dcode.org). ECR evolutionary conserved region, UTR
untranslated region. b Snapshot images of the SOX1 overlapping
transcript loci on human (hg19 chr13:112626600–112765500, top
panel) and mouse (mm9, chr8: 12,300,135–12,439,035) taken from
the UCSC genome browser to show the currently annotated structures
of these transcripts in the two species. The conserved region high-
lighted in grey corresponds to an annotated exon in the mouse Sox1
overlapping transcript Gm5607 but not in human LINC00403. Note
that the human gene AK055145 annotated 30 to LINC0403 partly
overlaps the 30end of the mouse Gm5607 which extends further than
the human transcript
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AK055145 annotated just 30 to the last exon of
LINC00403 may be part of some SOX1-OT transcript
variants in this cell type (Fig. 5c). This observation
appeared to better mirror the data obtained for the
annotated mouse Sox1-ot transcript Gm5607 (see human
and mouse locus comparison in Fig. 2b). The analysis was
extended to human neural tissue, through transcriptome
analysis of RNA-seq data available for developing human
A
B
R3
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Variant 2
F2 F1
R1
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SOX1
C
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RT-PCR
R7
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Fig. 3 SOX1-OT structure in ReN human neuroprogenitor cells.
a Schematic diagram showing SOX1-OT Variants 1 and 2 as
annotated in the UCSC human genome browser, showing the
evolutionary conserved region identified by cross-species comparison
(shaded green box), the positions (blue arrows) of the RT-PCR (F1,
R1, F2 and R3) and 50RACE (GSP1) primers, and the location of
SOX1 (orange arrow). b Transcript variants identified by RT-PCR
and 50RACE. Variants 3–5 were identified by RT-PCR using primers
within the conserved sequence (primers F1 and R1) in combination
with primers in annotated exons; variant 6 was amplified using primer
R7 in one of the newly identified exons from variant 6 and primer F2,
while variant 7 was amplified using primer F6 in the first exon
upstream of SOX1 identified by 50RACE (variants 8, 9 and 10).
50RACE products were amplified by anchoring the 50RACE in the
most 30 exons of the annotated LINC0403 (primer GSP1 in a).
c UCSC image of hg19 chr13:112626600–112765500 showing the
SOX1-OT sequences detected in ReN cells sequence (BLAT, top) and
the total count of CAGE reads (red peaks) from the FAMTON5
project track (bottom). Bent arrows indicate transcription start sites
(TSS) either newly identified (black) or previously annotated (grey).
For simplicity, diagrams in a and b are not to scale
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cortex [40]. This analysis identified a greater variety of
SOX1-OT transcript variants over increasing gestational
time points in developing cortex tissue than in the cell
samples used in this study (Supplementary Fig. 2). Nev-
ertheless, many were found to initiate at a transcription
start site (TSS) very close to, if not identical to, the TSS
detected by 50RACE. Evidence from this transcriptome
analysis also suggested that SOX1-OT may extend further
than its currently annotated 30 end.
Protein-coding gene AK55145 is part of SOX1-OT
To further investigate the 30 extent of the human SOX1-OT
transcript, primers within AK055145 (F12 and R12,
Fig. 6a) were used alone or in combination with primer F4
in the last annotated exon of LINC00403 to test expression
in D0 and D6 ReN cells (Fig. 6a).
RT-PCR detection of AK55145 gene expression (primer
pair F12–R12) showed that AK55145 was only detected in
differentiated ReN cells (Fig. 6b, top panel). Using primer
pair F4–R12, a product was amplified in D6 ReN cells
suggesting that the last exon from SOX1-OT and the
AK55145 gene may be part of the same transcript. To
confirm our findings, the PCR fragments amplified from
D6 cDNA and from gDNA were sequenced and aligned to
the genome using BLAT [29], confirming that the SOX1-
OT transcript extended to include the AK55145 gene.
Therefore, these results indicated that the locus of SOX1-
OT extends further downstream than the currently anno-
tated SOX1-OT transcript as shown in the UCSC genome
browser-generated images (Fig. 6c).
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Fig. 4 Differentiation of the ReN human neuroprogenitor cell line.
a Imaging of day 0 (control) and day 6 (differentiated) ReN cultures
in brightfield (left panels) and following immunostaining for NESTIN
and MAP2 (green) with corresponding dapi counterstain (blue). Bar
50 lm. b Relative quantification (RQ) of SOX1 mRNA expression
analysed by quantitative RT-PCR across the different time points of
ReN cells differentiation (day 0, 2, 4 and 6). Error bars represent
±RQ, n = 3, ***p\ 0.001; ****p\ 0.0001
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SOX1-OT expression correlates with SOX1 gene
expression in different cancer cell lines
Recently, several reports have suggested SOX1 involve-
ment in cancer development [41–43], and the present
study has investigated whether SOX1 gene expression
may correlate with expression of SOX1-OT in cancer. To
achieve this, SOX1 and SOX1-OT expression was anal-
ysed in a variety of cancer cell lines by RT-PCR using
different combinations of primer pairs across the locus
(Fig. 7a). Primer pair F4-R4 was used to detect the last
annotated exon of LINC00403 that is shared by several
SOX1-OT variants (see Fig. 3b). Expression of the SOX1
amplicon (primers F13–R13) was co-detected with that of
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Fig. 5 Expression profile of SOX1-OT during human neuroprogen-
itor differentiation. a Composite structure of the SOX1-OT genomic
locus including the exons (green boxes) and additional TSS (bent
arrows) newly identified in ReN cells; primers used in the expression
profiling are shown as blue arrows. b RT-PCR detection of SOX1-OT
exons 2, 7, 10 and transcript variants 3, 4, 5, 9, 11 in undifferentiated
ReN cells (D0) and at day 2 (D2), 4 (D4) and 6 (D6) of neural
differentiation. GAPDH was used as positive control for RT reaction.
c Schematic diagram of the SOX1-OT locus in ReN cells (top) with
indicated exons (numbered boxes) and TSS (bent arrows), and IGV
visualisation of the transcriptome assembly (bottom) for neural
differentiation time course of human embryonic stem cell-derived
neuroprogenitor cells compared to the SOX1-OT isoforms identified
in this study (top row). Green and red arrows show TSS detected
using 50RACE; the Sox1 region is shown between green vertical
lines; pink boxes show regions which differ between the SOX1-OT
isoforms detected in H1 hESC vs ReN cells; red circles highlight
SOX1 isoforms that merge with SOX1-OT isoforms. Note that some
of the transcripts in H1 hESC suggest that AK055145 is part of the
SOX1-OT transcript
Expression of a SOX1 overlapping transcript in neural differentiation and cancer models
123
the SOX1-OT F4–R4 region in most of the cell lines
analysed (Fig. 7B). SOX1 and SOX1-OT were co-detected
in teratocarcinoma (NTera) and some breast cancer
(MCF7, T47D) cell lines, but not in colon (HCT116,
CaCo-2), some breast (MDA-MB-231/361, Hs578T) and
cervical (HeLa) cancer cells (Fig. 7b). The exception to
this pattern was the osteoblast HOS cell line, which
expressed the SOX1 gene but not SOX1-OT, and the
neuroblastoma SH-SY5Y cell line which presented the
opposite pattern. Using primer pair F6–R3, we detected
SOX1-OT variants 8–10 that span the SOX1 gene, but no
SOX1-OT variant spanning the SOX1 gene was detected
in the cancer cell lines tested (Fig. 7c). Transcriptome
tracks for HeLa and MCF7 cells available through the
ENCODE project annotations were analysed and indi-
cated patterns consistent with our RT-PCR results,
showing HeLa cells negative throughout this region, while
some transcription could be seen in MCF7 cells across the
locus (Supplementary Fig. 3). These findings suggested
that SOX1-OT variants spanning the SOX1 gene are
expressed in MCF7 cells, but these appeared to have a
different structure to those found in ReN cells.
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Fig. 6 LINC00403 and AK055145 are part of SOX1-OT.
a Schematic diagram showing the positions of primers used in exon
10 of SOX1OT and within the annotated gene AK055145. b RT-PCR
product obtained using cDNA from ReN cells at day 0 (D0) and 6
(D6) of differentiation; genomic DNA (gen) was used as a positive
control for PCR. PCR F12-R12 was co-linear to the genomic DNA
and gave rise to a 462-bp product only detectable in D6 cells; F4–R12
amplicons spanned the region from exon 10 of LINC00403 and
AK055145 with an expected genomic size of 762 bp (2); this primer
pair detected a spliced product of 550 bp in D6 ReN cells (1) but not
in D0. c Sequences obtained for genomic and D6 ReN cDNA PCR
were aligned to the human genome assembly (GRCh37/hg19) using
blat and visualised using the UCSC genome browser (top box); an
enlargement of the blat alignment showed the D6 ReN product (1)
spanned from LINC00403 through to AK055145
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Fig. 7 SOX1 and SOX1-OT expression in a panel of human cancer
cell lines. a Schematic diagram of the SOX1-OT locus showing the
positions of the primer pairs used to detect SOX1 and different regions
of SOX1-OT in cancer cell lines. b RT-PCR detection of SOX1 and
SOX1-OT (exon 10) in the stated human cancer cell lines and in day 6
differentiated ReN cells as a positive control. c RT-PCR detection of
SOX1-OT variants 8–11 and exon 7 detected with the indicated primer
combinations in the stated human cell lines. PCRs performed on total
RNA after reverse transcription with (?RT) or without (-RT) reverse
transcriptase; M DNA size standard; H2O no template PCR negative
control
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Discussion
Characterisation of the structure of SOX1-OT
Genome-wide studies have reported large numbers of non-
coding RNAs whose function and significance are not clear.
To understand the complex transcriptome architecture,
expression and regulation of genetic information, it has
become necessary to distinguish betweenmRNA and ncRNA
transcripts [44]. Here we show that the SOX1-OT transcript,
annotated as a long intergenic non-coding mRNA-like tran-
script with no inferred coding potential, could be detected in
human cells. SOX1-OT has a complex structure including
several unannotated exons, different transcript variants, and at
least two potential TSS. Our data identified a total of 10 exons
for human SOX1-OT, 5 ofwhich (exon2, 3, 6–8) are novel and
previously unknown. In addition to the two annotated tran-
script variants (V1–V2), we report 9 new SOX1-OT transcript
variants (V3–V11) not previously reported in the literature.
Therefore, SOX1-OT presents complex transcriptional fea-
tures, whose potential functions and biological significance
remain to be explored. The TSS identified for human SOX1-
OT is located in close genomic proximity to and upstream of
the SOX1 gene (Fig. 1a), suggesting a possible role in regu-
lating SOX1 gene expression. The likelihood of SOX1-OT
acting as a regulator of SOX1 is supported by similarities with
the SOX2 locus. The multi-exon, non-coding SOX2-OT tran-
script overlapping SOX2 has recently been shown to give rise
tomultiple splice variants fromdifferentTSS, and is attributed
a positive regulatory role in SOX2 transcription [9].
Our results show that the first exon of the RefSeq-an-
notated transcript LINC00403 is either absent or expressed
at levels below the present detection limits in ReN cells.
However, it is important to note that the current annotated
structure of SOX1-OT has been obtained by combining
information collected from three different tissues types
(amygdala, eye, carcinoid); this might explain the differ-
ences with the present study, which focused on
characterising the transcript in a well-defined neural cell
type. Interestingly, the newly experimentally characterised
structure of human SOX1-OT resembles that of the anno-
tated mouse Sox1-ot. Both have TSS upstream of and near
to the SOX1 coding gene; moreover, although the 30 end of
the mouse overlapping transcript extends further down-
stream compared to the current annotation of the human
SOX1-OT, our findings extend human SOX1-OT to include
the downstream AK55145 gene, in line with the mouse
transcript 30 end. Our results suggest this 30 end might be
used in differentiated ReN cells and not in undifferentiated
cells; further work will be required to determine whether
Transcription Termination End (TTE) usage is regulated in
a cell type/tissue/differentiation stage specific manner.
Potential role of SOX1-OT in neural differentiation
as a regulator of SOX1
SOX1-OT was found to be highly expressed in differenti-
ated neural stem cells, and its expression appeared to
correlate with SOX1 gene expression. Different SOX1-OT
transcript variants were differentially detected during the
course of neural differentiation. Our observed correlation
between SOX1 and SOX1-OT expression during neural
differentiation is similar to that reported for Sox2 and Sox2-
ot during mouse neurosphere differentiation in vitro;
however, in this case both Sox2 and Sox2-ot were upreg-
ulated after day 2 and then slightly downregulated at day 7
of neural differentiation [5], while here SOX1 and SOX1-
OT were upregulated at day 2 and expression remained
upregulated towards day 6 of neural differentiation in vitro.
It is therefore possible that co-expression of SOX1-OT and
SOX1 during neural differentiation might indicate a co-
regulatory role in pathways regulating neural differentia-
tion. Furthermore, we observed a switch between transcript
variants 4 and 5 from day 2 to 4, further supporting a
possible regulatory role during neural differentiation. Fur-
ther experiments testing the effect of forced expression or
downregulation of the new transcript will be required to
determine if SOX1-OT plays a functional role in neural
differentiation and a possible link to SOX1 expression.
SOX1-OT and SOX1 are concomitantly expressed
in different cancerous cell lines
SOX1 expression has been already reported in several
cancer types [45–48]. We detected co-expression of SOX1-
OT and SOX1 RNAs in NTera, T47D and MCF7 cancer
cell lines. Concomitant expression of SOX2 and its
LncRNA SOX2-OT has been described in different cancer
types, and it was shown that SOX2 gene expression is
regulated by SOX2-OT in this context. For example, SOX2-
OT is upregulated together with SOX2 and OCT4 in
oesophageal squamous cell carcinoma [6]. Moreover, co-
expression of SOX2-OT and SOX2 has been previously
reported in the NTera cell line, and SOX2-OT has been
functionally associated with the SOX2 gene in pluripotency
and tumorigenesis [9]. Also, concordant expression of
SOX2 and SOX2-OT has been reported in breast cancer and
both are upregulated in cell suspension culture conditions
that favour stem cell expansion [7].
Our finding of SOX1-OT expression in the NTera cell line,
which possesses stemcell-like properties, indicates a potential
role of SOX1-OT in pluripotency and cancer development.
Similar to SOX2 and SOX2-OT, expression of SOX1-OT and
SOX1 in breast cancer cell lines (MCF7 and T47D) also
suggests a possible co-regulatory role in breast cancer.
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Therefore, SOX1-OT might have a potential role in
cancer by promoting SOX1 expression; its expression in
different cancer types in which SOX1 has already been
reported will need further investigation. Based on our data
and in silico analysis, it is possible that cells from different
tissues and/or different cell types from the same tissue may
express different repertoires of transcript variants, so fur-
ther larger scale expression analyses will be required to
identify all the isoforms, their structures and polyA sites.
Indeed, analysis of Poly-A seq data from both mouse and
human brain samples confirmed the presence of a vari-
ability of poly-A signals (Suppl. Figure 4). In the context
of cancer, the structure of alternative SOX1-OT variants
expressed in cancer types that express SOX1 will also
require consideration, in order to identify the repertoire of
transcript variants expressed through large-scale gene
expression and RACE analyses. Interestingly, the
osteosarcoma cell line HOS has been shown to express
SOX1 but not SOX1-OT, while in contrast the neuroblas-
toma cell line SH-SY5Y showed signal for SOX1-OT but
not SOX1. This observation indicates that SOX1 and SOX1-
OT expression might be independent of each other in these
cancer types, or there might be another regulatory mech-
anism for these two transcripts, which requires further
exploration.
Our results also indicate that the SOX1-OT locus extends
further downstream than the currently annotated SOX1-OT
transcript, suggesting that the gene AK055145 annotated
just 30 to the last exon of LINC00403 may be part of some
SOX1-OT transcript variants. Therefore, further experi-
ments such as 30RACE will be necessary to confirm this
initial observation.
Conclusion
In conclusion, we report the expression of an overlapping
transcript at the SOX1 locus, and have demonstrated that
SOX1-OT has a complex structure with two potential TSS
and multiple transcript variants. These transcript variants
are highly expressed in differentiating neuroprogenitors,
where their expression coincides with that of SOX1. Fur-
thermore, we have shown co-expression of SOX1-OT and
SOX1 RNA in neural and cancer cell lines, suggesting a
possible role for SOX1-OT in stem cell differentiation and
cancer. Further work is now needed to determine the
function of SOX1-OT and its potential regulatory link to
SOX1 expression.
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